Location:Home /  Resource
Past list
MGI Products for Exome Sequencing and Target Enrichment for Oncology
Release date:2021-10-14Writer:MGIViews:8457Share

Abstract:

This talk will focus on various target enrichment solutions that are being offered from MGI and 3rd party companies like Agilent, Twist, IDT, Paragon Genomics and Pillar Biosciences for Exome and Oncology samples. This talk further highlights a few total solutions: target enrichment followed by sequencing using MGI's DNBSEQ Platforms for whole exome for translational research, clinical exome and bioinformatics solutions for secondary analysis, interpretation and reporting.


Brief Bio:

Dr. Ravi has 18+ years of strong cross-functional domain expertise along with bioinformatics experience in Scientific support, Operations & business development and associated with

various Genomics (NGS/Microarray) based research projects and diagnostic applications. He has served at several positions in Genomics companies globally like MedGenome, Cancer Genetics Inc., VIMTA Labs, Genetech, and currently working as Head – India Technical Support and taking care of technical support across India and Business development. 12- peer reviewed articles

have been in his credit and four more manuscripts are being prepared/ready for submission.


Dr. Ravi Kumar Chilukoti
Dr. Ravi Kumar Chilukoti
Head – India Technical Support
MGI, a member of BGI

If you have any questions, you can send an email to:
MGI-service@mgi-tech.com
  • Hotline (Global)
    +86-4000-688-114
  • Email
    MGI-service@mgi-tech.com
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2024 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies